‍Wound care audits are often triggered by unusual billing patterns or high utilization of costly treatment products. Medicare contractors use data analytics to flag providers who bill large volumes of skin substitutes or allograft materials (like placenta-based grafts) or who reapply products more frequently than peers. If your clinic’s billing stands out it may prompt an audit. Sometimes audits stem from a whistleblower complaint or as part of a broader industry crackdown, as recently seen in DOJ’s Healthcare Takedown and OIG 2025 Skin Substitute Payment Trends Report. In short, any provider using advanced wound care products at scale can be subject to review, even if you believe your practices are compliant.

If you are a healthcare provider who frequently treats Medicare beneficiaries with advanced skin substitute products such as NuShield, Grafix, Integra, Apligraf, WoundFix, TheraSkin, Dermagraft, Apligraf, Xenografts, Permacol, Matriderm, Oasis, Biobrane, AWBAT, Integra, AlloDerm, Graftjacket, GammaGraft, Stravix, or Orcel, there is a high probability that your practice will be audited. Podiatrists, wound care certified healthcare providers, mobile wound clinics, and advanced wound care centers are facing particular scrutiny given the high volume of complex wounds that such practices encounter.

Wound care audits tend to hone in on documentation weaknesses. Common issues include:

‍

Lack of medical necessity detail: Auditors often claim the records don’t clearly justify using an expensive graft. For instance, not documenting prior conservative treatments (standard dressings, debridement, etc.) before turning to advanced wound products can be a red flag. You need to show why the advanced therapy was needed.

‍

Incomplete wound measurements and progress notes: Medicare expects thorough documentation of the wound’s size, depth, and healing progress with each application. If your charts lack before-and-after measurements or detailed wound assessments at each visit, auditors may decide the reapplications weren’t justified.

‍

Not documenting usage and wastage: Failing to record the exact amount of product used (and any wasted portion with lot numbers) is a frequent citation. Auditors want to ensure you aren’t over-billing by using less graft than billed or reusing materials improperly.

‍

“Cloned” or generalized notes: Using identical language for multiple patients or visits can suggest cookie-cutter care. Auditors look for patient-specific documentation – why this product for this patient, evidence of tailoring the plan. If notes are too generic, they may deny claims for lack of individualized justification.

‍

Off-label or non-covered use: Some skin substitutes are only covered for certain indications. If documentation doesn’t clearly stay within coverage guidelines or FDA-approved use (for example, using a placental allograft for an unapproved purpose without justification), those services will likely be denied as not reasonable or necessary.

Being aware of these common pitfalls can help providers improve their records. But if you’re already in an audit, a lawyer will scrutinize the cited documentation issues and counter any unfair or incorrect conclusions the auditors draw.